Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10626147
Cell penetrating peptides and methods of making and using thereof
granted -
US 10626096
Azole derivatives as apelin receptor agonist
granted -
US 10626087
Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same
granted -
US 10626111
Modulators of ATP-binding cassette transporters
granted -
US 10624968
Compounds for treating cancer
granted -
US 10626396
Antisense composition and method for treating muscle atrophy
granted -
US 10626372
Methods and compositions for inducing hematopoietic cell differentiation
granted -
US 10624878
Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
granted -
US 10624379
Composition, method for producing the same and use thereof
granted -
US 10626173
Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR
granted -
WO 2020074463
COMPOSITION LIQUIDE ORALE COMPRENANT DU TRIPTAN
granted -
CA 3112060
COMPOSITION PHARMACEUTIQUE COMPRENANT UN ANTAGONISTE DE GPRP RADIOMARQUE ET UN TENSIOACTIF
granted -
US 10618968
Antigen-binding proteins that activate the leptin receptor
granted -
US 10617757
Methods for treating multiple myeloma
granted -
US 10618967
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
granted -
US 10618877
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
granted -
US 10617709
miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers
granted -
US 10617673
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted -
US 10619154
Nuclease-mediated regulation of gene expression
granted -
US 10619153
TAL effector-mediated DNA modification
granted -
US 10618983
Hyaluronic acid-based hydrogels having medical applications
granted -
US 10618938
Compositions for colon cleansing and the treatment of gastrointestinal disorders
granted -
US 10617667
Method for treating brain tumors
granted -
US 10620204
Antibody-mediated neutralization of Ebola viruses
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.